Table 3. Clinical outcomes for all studies included.
| Study | Postoperative mortality (%) | Postoperative morbidity (%) | Anastomotic leak (%) | Pulmonary complications (%) | R1/2 resection margin (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salv | NCRS | Salv | NCRS | Salv | NCRS | Salv | NCRS | Salv | NCRS | |||||
| Miyata | 12 | 4 | – | – | 39 | 13 | – | – | 12 | 12 | ||||
| Morita | 7.4 | 2 | 59 | 40 | 37 | 23 | 29.6 | 14.7 | 29.6 | 22.8 | ||||
| Takeuchi | 5 | 8 | – | – | 24 | – | 44 | 25 | 20 | 22.5 | ||||
| Markar | 8.4 | 9.3 | 63.6 | 58.9 | 17.2 | 10.7 | 42.9 | 40.9 | 12.7 | 11 | ||||
| Marks | 4.6 | 5.2 | – | – | 18.5 | 11.3 | 23.1 | 17.9 | 9.2 | 5.4 | ||||
| Nakamra | 3.7 | 0 | – | – | 3 | 1 | 22.2 | 14.3 | 33 | 39 | ||||
| Swisher | – | 6 | – | – | 38 | 7 | – | – | – | – | ||||
| Smithers | 7 | 2 | 79 | 62 | 14 | 8 | 57 | 30 | – | – | ||||
| Farinella | 0 | 0 | 44 | 37.5 | 25 | 3 | 37.5 | 28 | 19 | 3 | ||||
| Tomimaru | 12.5 | 0 | 50 | 23.1 | 11.5 | 11.5 | 20.8 | 11.5 | 33.3 | 11.5 | ||||
| Chao | 22.2 | 7.9 | – | – | 14.8 | 1.1 | 33.3 | 11.5 | 37.1 | 15.7 | ||||
Salv, salvage esophagectomy; NCRS, neoadjuvant chemoradiotherapy.